https://biotechmorning.com/news/iambic-therapeutics-ipo-150-million Biotech Morning en 2026-10-15T14:14:43.430Z The AI Cancer Startup That Just Talked Wall Street Into $150 Million https://biotechmorning.com/news/ipf-claims-another-victim-syndax-stock Biotech Morning en 2026-10-15T14:13:56.057Z IPF Claims Another Victim (and Syndax's Stock Pays the Price) https://biotechmorning.com/news/astrazeneca-insitro-ai-mash-deal Biotech Morning en 2026-10-15T14:13:10.858Z AstraZeneca Just Bet $1.5 Billion That AI Can Crack the Liver https://biotechmorning.com/news/vertex-10-billion-crinetics-acquisition-5 Biotech Morning en 2026-10-15T14:12:19.049Z Vertex Just Dropped $10 Billion on a Company Most People Haven't Heard Of https://biotechmorning.com/news/agilent-proscia-240m-digital-pathology-acquisition Biotech Morning en 2026-10-15T14:11:39.314Z Agilent Just Paid $240M for a Company That Started in a Dorm Room https://biotechmorning.com/news/fda-rare-disease-framework-overhaul Biotech Morning en 2026-10-15T14:10:50.550Z The FDA Just Admitted Its Rare Disease Playbook Is Broken https://biotechmorning.com/news/mit-in-vivo-nk-cell-reprogramming-nanoparticles Biotech Morning en 2026-10-15T14:10:02.844Z What If You Could Skip the Factory and Build Cancer-Killing Cells Inside the Body? https://biotechmorning.com/news/arrowhead-aro-mapt-tau-rna-alzheimers Biotech Morning en 2026-10-15T14:09:21.035Z Arrowhead Found a Way to Quiet the Brain's Most Toxic Protein https://biotechmorning.com/news/omass-therapeutics-310-million-series-c Biotech Morning en 2026-10-15T14:08:32.038Z Britain's Bid to Build a Biotech Giant Just Got $310 Million Louder https://biotechmorning.com/news/anktiva-bladder-cancer-label-expansion Biotech Morning en 2026-10-15T14:07:44.787Z The Bladder Cancer Drug That Just Got a Bigger Playground https://biotechmorning.com/news/legend-biotech-in-vivo-car-t-lb2501 Biotech Morning en 2026-10-15T14:07:03.420Z What If Your Body Could Build Its Own Cancer-Killing Cells? https://biotechmorning.com/news/sanofi-caught-trash-talking-rival-vaccine Biotech Morning en 2026-10-14T14:18:32.342Z Sanofi Got Caught Trash-Talking a Rival Vaccine https://biotechmorning.com/news/glp1-graveyard-getting-crowded Biotech Morning en 2026-10-14T14:17:46.324Z The GLP-1 Graveyard Is Getting Crowded https://biotechmorning.com/news/zealand-generate-ai-obesity-protein-deal Biotech Morning en 2026-10-14T14:17:01.234Z Zealand Just Bet $1.2 Billion That AI Can Design the Next Obesity Drug https://biotechmorning.com/news/gsk-billion-dollar-idrx-gist-acquisition Biotech Morning en 2026-10-14T14:16:15.974Z GSK Just Spent $1 Billion on a Cancer You've Probably Never Heard Of https://biotechmorning.com/news/pfizer-enodia-protein-degradation-deal Biotech Morning en 2026-10-14T14:15:28.194Z Pfizer's Half-Billion-Dollar Bet on Killing Proteins Before They're Born https://biotechmorning.com/news/syndax-walks-away-ipf-lung-disease Biotech Morning en 2026-10-14T14:14:38.349Z Syndax Just Walked Away From a Billion-Dollar Lung Disease https://biotechmorning.com/news/otsuka-rexulti-ptsd-fda-adcom-skepticism Biotech Morning en 2026-10-14T14:13:51.027Z Otsuka's Big Bet on a PTSD Pill Just Hit a Wall at the FDA https://biotechmorning.com/news/keytruda-first-biosimilar-fda-review Biotech Morning en 2026-10-14T14:13:06.633Z The $32 Billion Drug That Just Got Its First Real Challenger https://biotechmorning.com/news/novartis-abogen-rna-deal Biotech Morning en 2026-10-14T14:12:26.585Z Novartis Just Bet $7.8 Billion That Your Body Can Build Its Own Medicine https://biotechmorning.com/news/gilead-vir-biotechnology-masked-tce-deal Biotech Morning en 2026-10-14T14:11:42.330Z Gilead Just Bet $1.9 Billion on a Cancer Drug That Wears a Disguise